Diffuse (interstitial) lung disease includes a wide variety of relatively uncommon conditions presenting with characteristic clusters of clinical features and marked by an immune response.

The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is ...

Interstitial lung disease (ILD) causes significant morbidity and mortality in patients with systemic autoimmune rheumatic diseases. Patients at high risk of ILD should be screened using high ...

Interstitial Lung Disease (ILD) is a clustering of the diseases which comprises inflammation and scarring (fibrosis) of the ...

Interstitial lung disease (ILD), a condition characterized by inflammation and fibrosis, is a major cause of severe respiratory illness ... In a head-to-head study, FAPI PET/CT was found to be ...

The following is a summary of “Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis ...

In cases of pulmonary fibrosis attributable to interstitial lung disease, whether the aetiology is known or unknown, the ...

Enniskillen author and charity trustee Clare Donohoe recently addressed the Interstitial Lung Disease (ILD) Interdisciplinary ...

Enniskillen author and charity trustee Clare Donohoe recently addressed the Interstitial Lung Disease (ILD) Interdisciplinary Network conference ...

The Pulmonary Fibrosis Foundation (PFF), the nation's leading pulmonary fibrosis (PF) research, education and advocacy ...

Opens in a new tab or window Type 2 diabetes (T2D) appeared to double the risk of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA), according to a retrospective cohort study.

Interstitial Lung Disease (ILD) is a chronic condition marked by lung inflammation and scarring that makes breathing difficult. Early diagnosis is vital for effective management. Contributing ...